A. John Barrett spends much of his time researching Immunology, Transplantation, Internal medicine, Leukemia and Bone marrow. His work carried out in the field of Immunology brings together such families of science as Hematopoietic stem cell transplantation and Graft-versus-host disease. His research integrates issues of Human leukocyte antigen and Fludarabine in his study of Transplantation.
The various areas that A. John Barrett examines in his Internal medicine study include Gastroenterology, Surgery and Oncology. The study incorporates disciplines such as Myeloid, Graft-vs-Leukemia Effect, Myeloid leukemia and FOXP3 in addition to Leukemia. His biological study spans a wide range of topics, including Progenitor cell, Alemtuzumab and T lymphocyte.
His scientific interests lie mostly in Immunology, Transplantation, Internal medicine, Stem cell and T cell. His Immunology research integrates issues from Hematopoietic stem cell transplantation and Graft-versus-host disease. His biological study deals with issues like Bone marrow, which deal with fields such as Haematopoiesis.
He has researched Internal medicine in several fields, including Gastroenterology, Surgery and Oncology. His Stem cell research incorporates elements of Adoptive cell transfer and Immunotherapy. His research in T cell intersects with topics in Epitope, Antigen and Cytotoxic T cell.
A. John Barrett mainly investigates Immunology, Transplantation, Internal medicine, Leukemia and Stem cell. His Immunology study incorporates themes from Cytotoxic T cell and Hematopoietic stem cell transplantation. A. John Barrett is interested in Graft-versus-host disease, which is a field of Transplantation.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology. His studies deal with areas such as Myeloid, Cancer research, Antigen and Lymphoma as well as Leukemia. His study in Stem cell is interdisciplinary in nature, drawing from both Immune system, Lymphocyte and Cardiology.
His main research concerns Immunology, Hematopoietic stem cell transplantation, Transplantation, Stem cell and Bone marrow. His Immunology study frequently draws parallels with other fields, such as Cytotoxic T cell. His Transplantation study is related to the wider topic of Internal medicine.
In his work, Lupus erythematosus, Autoimmune disease and Cytokine is strongly intertwined with Lymphocyte, which is a subfield of Stem cell. His Bone marrow research is multidisciplinary, relying on both Dyslipidemia, Hematologic disease, Myeloid leukemia, Mesenchymal stem cell and Risk factor. His biological study spans a wide range of topics, including Gastroenterology and Letermovir.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden.
Graft-versus-leukemia reactions in allogeneic chimeras
Hans-Jochem Kolb;Hans-Jochem Kolb;Christoph Schmid;Christoph Schmid;A. John Barrett;A. John Barrett;Dolores J. Schendel;Dolores J. Schendel.
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.
Katayoun Rezvani;Stephan Mielke;Mojgan Ahmadzadeh;Yasemin Kilical.
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Conrad Russell Y. Cruz;Kenneth P. Micklethwaite;Barbara Savoldo;Carlos A. Ramos.
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.
Katayoun Rezvani;Agnes S.M. Yong;Stephan Mielke;Bipin N. Savani.
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome
Maryalice Stetler-Stevenson;Diane C. Arthur;Nicholas Jabbour;Xiu Y. Xie.
Antithymocyte globulin for patients with myelodysplastic syndrome
Jeffrey J. Molldrem;Mary Caples;Dimitrios Mavroudis;Michelle Plante.
British Journal of Haematology (1997)
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Yogen Saunthararajah;Ryotaro Nakamura;Jun Mo Nam;Jamie Robyn.
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.
Katayoun Rezvani;Matthias Grube;Matthias Grube;Jason M. Brenchley;Jason M. Brenchley;Giuseppe Sconocchia;Giuseppe Sconocchia.
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Geoff Hale;Mei-Jie Zhang;Donald Bunjes;H. Grant Prentice.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: